TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
AVIR

Atea Pharmaceuticals Inc

Healthcare · Biotechnology

5.20$ -2.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow AVIR
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – -129.3% – – – –
– +0.0% +11.8% +52.6% +796.6% +60.0% +0.0% +0.0%
– +50.7% +1,095.0% +431.3% +17.9% +5.8% +4.7% -60.0%
– +50.7% +1,095.0% +431.3% +4.1% – – –
– -20.1% +51,748.9% -182.6% – – -146.3% –
– -83.3% +1,200.0% -84.6% +48,475.0% -100.0% – –
– -83.3% +1,200.0% -84.6% +11,385,150.0% – +39.2% +236.5%
– – – -99.7% – – – –
– -100.1% – -99.7% -74.7% -30.5% +3.9% -9,742.3%
– -165.6% – -110.3% – – – –
– – – -129.3% – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?